Nanion Technologies Announces the Winners of the SURFE²R Grant Award ? a Platform for Membrane Transporter Research and Screening
Nanion today announced two winners of the SURFE²R N1 grant award. Dr. Camilo Perez and Dr. Dimitrios Fotiadis convinced the grant committee with their proposed research projects
(PresseBox) - Transporter proteins are gaining increasing interest in academic science and as therapeutic targets. Nanion?s two platforms, SURFE
Earlier this year, Nanion announced the SURFEecision.
Dr. Maria Barthmes, SURFE
The committee has therefore decided to grant two applicants the use of the SURFE
The SURFE
Prof. Dr. Camilo Perez
Biozentrum (The Center for Molecular Life Sciences), University of Basel, Switzerland
Title of the project: ?Novel cell wall synthesis blockers: characterization of inhibitory nanobodies by SSM-based electrophysiology?
Prof. Dr. Dimitrios Fotiadis
Institute for Biochemistry and Molecular Medicine, University of Bern, Switzerland
Title of the project: ?Electrogenic transporters from the solute carrier (SLC) families 7, 15 and 16: From function to deorphanization?
We congratulate the winners and are looking forward to seeing exciting results in the coming year.
Nanion Technologies is a leading provider of instrumentation for ion channel drug discovery and screening. Founded in 2002, Nanion has grown over the last 17 years to a company with over 100 employees worldwide. With headquarters in Munich, Germany, Nanion has subsidiaries in the USA, Japan, China and Denmark, as well as distribution partners in seven other countries.
Nanion?s team has developed and successfully established four generations of automated patch clamp instruments for sophisticated and high throughput applications in ion channel research and drug discovery (Port-a-Patch, Patchliner and SyncroPatch product families).
Further product lines are for cell monitoring and cardiotoxicity screening (CardioExcyte 96), for parallel bilayer recordings (Orbit family), and for parallel membrane transporter protein recordings (SURFE
For more information, please visit www.nanion.de
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Nanion Technologies is a leading provider of instrumentation for ion channel drug discovery and screening. Founded in 2002, Nanion has grown over the last 17 years to a company with over 100 employees worldwide. With headquarters in Munich, Germany, Nanion has subsidiaries in the USA, Japan, China and Denmark, as well as distribution partners in seven other countries.Nanion?s team has developed and successfully established four generations of automated patch clamp instruments for sophisticated and high throughput applications in ion channel research and drug discovery (Port-a-Patch, Patchliner and SyncroPatch product families).Further product lines are for cell monitoring and cardiotoxicity screening (CardioExcyte 96), for parallel bilayer recordings (Orbit family), and for parallel membrane transporter protein recordings (SURFE²R).For more information, please visit www.nanion.de
Datum: 31.10.2019 - 06:20 Uhr
Sprache: Deutsch
News-ID 1553531
Anzahl Zeichen: 3048
contact information:
Contact person:
Town:
München
Phone:
Kategorie:
Handcrafts
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 1004 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Nanion Technologies Announces the Winners of the SURFE²R Grant Award ? a Platform for Membrane Transporter Research and Screening
"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanion Technologies GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
